First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Abroad (travel likely)RecruitingPHASE1
Conditions
Parkinsons Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada
Center for Human Drug Research, Leiden, South Holland, Netherlands
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals